Plain-English translation of NCT05717803 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a surgical technique called segmentectomy for treating a specific type of early lung cancer called ground glass-dominant invasive lung adenocarcinoma. Segmentectomy removes only a small segment of the lung rather than an entire lobe, which may help preserve more lung function. The study will follow patients for 5 years after surgery to see how well they do and how their breathing function changes.
Doctors want to know if this lung-sparing surgery works just as well as larger surgical removal for this type of early cancer, while potentially preserving more of the patient's lung function after treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo segmentectomy surgery to remove a small segment of your lung containing the cancer. After surgery, you will have follow-up visits where doctors will check your recovery, test your lung function, and monitor you for cancer recurrence. The study will track your health for 5 years after your surgery to measure how well the treatment worked and how your breathing function has been affected.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China